TET1, the first identified TET dioxygenase enzyme, was discovered in the early 2000s as the fusion partner to MLL in two cases of AML containing t(10, 11) translocations, one being in an 8‐year old patient.160, 161. Here, TET1 is linked to acute myeloid leukemia.